Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've noticed your skin burning more quickly since starting Mounjaro, you're not alone in asking about it. Tirzepatide is not officially listed as causing photosensitivity, but several things that change on treatment — including reduced fluid intake, altered skin barrier and injection-site sensitivity — can make sun exposure feel more uncomfortable or risky than it did before. This is a prescription-only medicine, and any skin changes worth you while on tirzepatide should be discussed with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a reasonable thing to notice. You spend a few hours in the garden, the same amount of time you'd have managed without issue last summer, and your skin is angrier than expected. The first thing to understand is that tirzepatide is not classified as a photosensitising medication. Unlike some antibiotics, diuretics or NSAIDs, it does not chemically sensitise your skin to UV radiation. So the mechanism, if there is one, is indirect rather than pharmacological.
What does change on Mounjaro is your appetite, and with it, often, how much you eat and drink. Many people on GLP-1 treatment find they're taking in significantly less fluid without realising it. Dehydration affects the skin's elasticity and barrier function, and skin that is already dry or losing tone can sunburn faster and recover more slowly. The NHS medicines page for tirzepatide lists dehydration as a risk during periods of significant nausea, vomiting or diarrhoea, and that guidance extends to the everyday context of simply drinking less because you're less hungry.
There is also the question of body composition. As weight comes off, subcutaneous fat thins. Fat beneath the skin provides a modest buffer against heat and some UV; as it reduces, that buffer reduces too. This is not unique to tirzepatide (it applies to any significant intentional weight loss) but it's worth factoring in if you've been on treatment for several months and notice a change in how you tan or burn. If you want to understand more about how Mounjaro affects fat stores during treatment, that page goes into the detail behind the weight-loss process.
Injection-site reactions are among the more commonly reported side effects with Mounjaro. Redness, itching and mild swelling around the injection point are listed in the SmPC and do settle for most people. What is less often discussed is how heat and sunlight can aggravate these local reactions. If you inject into your abdomen and then spend the afternoon lying in the sun on your front, you're applying UV and heat directly to already-irritated tissue.
The guidance from the Mounjaro patient information leaflet is to rotate your injection sites across the abdomen, thigh and upper arm. A practical addition, if you know you'll be outside: try to avoid applying sunscreen directly over a very recent injection site while it's still red, as some chemical sunscreen ingredients can interact with already-sensitised skin. Mineral sunscreens (zinc oxide, titanium dioxide) are generally gentler options for reactive skin. And keep your pen stored correctly, the pen needs refrigeration between 2°C and 8°C, and the KwikPen is not something you want sitting in a beach bag in direct sun. Check the exact in-use storage window in your patient information leaflet rather than guessing.
If you're curious about whether tirzepatide has any broader effects on body fat and composition, our page on tirzepatide and belly fat covers what the clinical evidence does and doesn't say.
Most mild redness after sun exposure on Mounjaro is ordinary sunburn, managed with the same approach as always: shade, cool water, a plain moisturiser, and much more fluid than you think you need. The dehydration point is particularly relevant here, if you've been outside and suspect you've not drunk enough, treat that first.
The reactions that warrant a call to your prescriber or pharmacist are those that don't fit the pattern of ordinary sunburn: a rash that spreads beyond sun-exposed areas, blistering without a clear cause, significant swelling especially around the face or throat, or any sign of an allergic reaction. These are rare but they do appear in the tirzepatide safety profile, and the MHRA Yellow Card scheme exists precisely so that unexpected reactions get reported and tracked. A skin reaction you can't explain is worth documenting.
There's a related question some people ask, whether UV exposure from sunbeds carries additional risk on tirzepatide. That's covered separately, but the short version is the same: the risk is mostly indirect, via dehydration, injection-site irritation and the skin changes that accompany weight loss, rather than a direct drug-UV interaction.
Questions about Mounjaro's broader effects (including whether it affects muscle mass during weight loss, and what the evidence actually says about sun sensitivity) come up often. Both pages go into more detail if you want to read further.
Mounjaro is a prescription-only weight-management treatment, and suitability is assessed individually by a prescriber. If you have questions about how your skin is responding on treatment, or about anything else that's changed since you started, our prescribers are available seven days a week. Speak to our prescribers through a free consultation, your questions get a real clinical answer, not a chatbot reply.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.